Layer 1

Generics shortages: has the government been forced to take action?

Generics shortages: has the government been forced to take action?

The latest instalment in the sector’s long-running struggles with generic pricing started in September 2017, when the Pharmaceutical Services Negotiating Committee (PSNC) pushed for “urgent discussions” with the Department of Health and Social Care (DH) about the “catastrophic” effect of generics shortages – caused by the temporary closure of two manufacturing sites – on contractors' cashflow.

By May, the British Generic Manufacturers Association (BGMA) had told C+D that while the generics shortages had “pretty much” been rectified  by other manufacturers “filling the gap”, prices remained unstable.

Fast forward to June, and a National Audit Office (NAO) report into the “unexpected increase” in generics prices in 2017 referred to government evidence of “unexpected increases in wholesalers’ margins, which [the DH] could not fully explain”.

The

Want to read more ?

Login or Subscribe to Update Plus to continue reading our CPD content.

Job of the week

Pharmacy Manager - Bridlington
Bridlington
Competitive plus benefits (GPhC fees incl)